Category: Health Care Costs

Everyone knows drug prices are a problem … except pharma

Health care experts, physicians, researchers, health plans, policymakers, Medicaid directors, patients – they all recognize how dangerous dramatic drug price increases are becoming for our patients and our health care system. As this week’s news coverage showed, pharmaceutical companies are still oblivious to how their six-figure price tags affect patients who need lifesaving treatments. Continue reading

Posted in: Health Care Costs, What They Are Saying

Rx News Roundup: New Drugs, Higher Prices

High-cost specialty drugs continue to fill drug pipeline, and with new FDA approvals come increased prices and increased spending. Continue reading

Posted in: Health Care Costs

New Issue Brief on Specialty Drug Issues and Challenges

A new issue brief from AHIP delves deeper into the challenges posed by high specialty drug pricing, which continues to threaten the availability of affordable coverage options for patients across the country. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

What’s behind health insurance premiums?

With recent discussions surrounding insurance premiums, it’s important to acknowledge an important fact: Premiums track directly with the underlying cost of care. Continue reading

Posted in: Health Care Costs

New Data Brief on Hospital Consolidation and Premiums

The growing body of evidence that hospital consolidation and higher premiums go hand-in-hand has yet another entry. A new AHIP data brief finds that as hospital consolidation increases, so too do premiums. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Rx News Roundup: Lower Prices and More Transparency

Leading oncologists are challenging exorbitant drug prices and making headlines this week by unveiling new tools aimed at driving value in cancer care. Continue reading

Posted in: Health Care Costs

Nearly $1 trillion in the next 5 years

Global prescription drug sales will grow 4.8 percent a year until reaching $987 billion by 2020, according to a new report from EvaluatePharma. Other findings from the report upend the concept that that research and development costs are driving high prescription drug prices. Continue reading

Posted in: Health Care Costs, Uncategorized

AHIP Briefing: Focus on the Price

Several stakeholders gathered in Washington, D.C., this morning for a panel discussion titled “Cost of Innovation: How the Future Drug Pipeline Will Impact Patient Access, Affordability.” Continue reading

Posted in: Health Care Costs

$50 billion is just the tip of the iceberg

With roughly 5,400 drugs in the pipeline, the issue of sustainable pricing is more important than ever. Continue reading

Posted in: Health Care Costs

Too Expensive

While drug manufacturers turn a blind eye to the fact that they charge some of the highest prices in the world, patients are paying attention – and they’re not happy about it. Continue reading

Posted in: Health Care Costs, Uncategorized